Sun Pharma gains 4% in 2 days after launching cough syrup Chericof 12

Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug

Shares of Sun Pharmaceuticals Industries were up nearly 2 per cent at Rs 792.85 on the BSE in Wednesday’s intra-day trade, gaining 4 per cent in the past two trading days, after the company launched a novel formulation in cough management, Chericof12 (Dextromethorphan Hydrobromide 30mg and Chlorpheniramine Maleate 4 mg) in India. The stock of the pharmaceutical company was trading close to its 52-week high level of Rs 804.40 touched on August 3, 2021.

Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the